Currently, Dr. Ballman is the Biostatistics Core director for the SARC Sarcoma SPORE. Dr. Ballman has considerable experience and expertise in cancer research that includes study design, analysis, and interpretation for clinical trials, translational studies, and basic research studies.
She also has experience in the development and conduct of clinical trials in cancer at all stages: phase I, phase II, and phase III as well as the development of genomic based signatures for prognostic and predictive purposes.